Header Logo

Connection

Mei Rui to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Mei Rui has written about Antibodies, Monoclonal, Humanized.
Mei Rui
Connection Strength
0.232
Antibodies, Monoclonal, Humanized
  1. Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma. J Immunother Cancer. 2024 Jun 21; 12(6).
    View in: PubMed
    Score: 0.232
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.